Remember Hisashi Moriguchi? He’s the fellow who claimed to have transplanted cells made from induced pluripotent stem (iPS) cells into human patients, to have worked at Harvard, and so forth. It all turned out not to be true. He even admitted it. Now Moriguchi is back in the news. He has several more papers published …
Moriguchi 2.0: more papers, more claims, and a new mysterious co-author Read More »
Cellular Dynamics, the stem cell company founded by Dr. James Thomson, is filing for an IPO. Hat tip to David Jensen. The company, which will go under the stock symbol ICEL, is focused on iPS cell-produced products. They describe their portfolio as follows: Cellular Dynamics is developing and deploying a number of cell types derived from …
Cellular Dynamics IPO: big money, iPS cell IP rights, trade secrets Read More »
One of the more exciting stem cell biotechs out there today is Advanced Cell Technology (ACT). At this time ACT has the only two ES cell-based FDA-approved clinical trials ongoing and so far they have looked quite promising in terms of preliminary safety data. However, ACT has much more in the pipeline including potentially iPS …
Interview with Gary Rabin of Advanced Cell Technology (ACT) Read More »
Was sind Stammzellen? Der menschliche Körper enthält Hunderte von verschiedenen Zellarten, die für unsere tägliche Gesundheit wichtig sind. Diese Zellen sind verantwortlich für das tägliche Funktionieren unseres Körpers, wie das Schlagen des Herzes, das Denken des Gehirns, das Säubern unseres Blut durch die Nieren, das Ersetzen unsere Hautzellen, und so weiter. Die wichtige und einzigartige …
In the coming weeks and months, I am going to run a series of posts (some interviews, some guest posts) on human reproductive cloning. This is the kind of cloning where you take a person (living or dead) such as, let’s say Lady GaGa or Jesus, and you try to make a duplicate new human …
Series on scientific & bioethics leaders discussing human reproductive cloning Read More »
Advanced Cell Technology (ACT) is well into clinical trials for macular degeneration (the leading cause of blindness) using human embryonic stem cell (hESC)-based retinal pigmented epithelial cells (RPE). To date, the trials suggest the products are safe. Efficacy? We don’t know. I am cautiously hopeful, but it is frustrating to know that most clinical trials …
It has been a big week in very different ways for the stem cell field related to induced pluripotent stem (iPS) cells. First, we had the Nobel Prize deservedly going to stem cell hero, Shinya Yamanaka. Great news! Congratulations to Dr. Yamanaka. Unfortunately, now, we have a puzzling story that iPS cells have been reported …
What are stem cells in Italian? Cosa sono le cellule staminali? Il corpo umano contiene centinaia di tipi cellulari divesi, che sono di primaria importanza per la nostra salute quotidiana. Queste cellule sono responsabili di mantenere i nostri corpi funzionanti, in modo che il cuore batta, il cervello pensi, i reni depurino il sangue, la …
Sometimes a top scientist makes news with a quote on research and that happened with Ian Wilmut recently on stem cells. Move away from research on human ES cells (hESC) in favor of very new and still largely unclear trans-differentiation technology? I say, no way. But, Bradley Fikes of the North County Times has reported …
Ian Wilmut, Dolly’s dad, says dump hESC? What does this mean? Read More »
I have posted before about publishing trends in the iPS cell field here and in here…. but where do things stand today? Here, I provide an important update. What’s going on now? Here I provide answers to the key questions. How many papers are there on iPS cells? An interesting and unexpected trend for this …
Everything you need to know about publishing in the iPS cell field Read More »